Inventor

MAGUIRE MARTIN P

CA34 patents

⚠️ This page may combine multiple inventors who share the name “MAGUIRE MARTIN P”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MAGUIRE MARTIN P

AVENTIS PHARMA INC

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and /or p56lck tyrosine kinases

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

RHONE POULENC RORER PHARMA

Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase

Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties

Aryl and heteroaryl quinazoline compounds which inhibit EGF and/or PDGF receptor tyrosine kinase

Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase

Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase

Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase

Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase

Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase

Polyarylcarbamoylaza- and -carbamoylalkanedioic acids

MILESTONE PHARMACEUTICALS INC

Short acting phenylalkylamine calcium channel blockers and uses thereof

Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereof

Short acting phenylalkylamine calcium channel blockers and uses thereof

Short acting phenylalkylamine calcium channel blockers and uses thereof

Short acting phenylalkylamine calcium channel blockers and uses thereof

Short acting phenylalkylamine calcium channel blockers and uses thereof

Short acting phenylalkylamine calcium channel blockers and uses thereof

AVENTIS PHARM PROD INC

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases

Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase

MILLENNIUM PHARM INC

Melanocortin-4 receptor binding compounds and methods of use thereof

AVENTIS PHARMACETICAL PRODUCTS

Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase

AVENTIS PHARMA GMBH

Compounds having antihypertensive, cardioprotective anti-ischemic and antilipolytic properties

ABBOTT LAB

Antagonists of melanin concentrating hormone receptor

ORE PHARMACEUTICALS INC

Melanocortin-4 receptor binding compounds and methods of use thereof

MAGUIRE MARTIN P

Short acting benzothiazepine calcium channel blockers and uses thereof